text:
UNC Lineberger News
A good heart
High school dropout, Green Beret medic who served three tours in Iraq, Special Forces medic instructor at Fort Bragg, lymphoma fighter who is free of cancer today, and future physician and researcher -- the remarkable path to medicine of rising third-year UNC medical student Eric Strand.
UNC Lineberger discovery could lead to personalized colon cancer treatment approach
In a study published in Nature Medicine, UNC Lineberger Comprehensive Cancer Center researchers report their findings of just how a certain tumor-suppressing protein helps prevent colon cancer. With this discovery, the researchers believe they've found a possible drug target for colon cancer patients who lack the tumor suppressor.
Hospital performance, from the patient's perspective
A UNC Lineberger Comprehensive Cancer Center researcher led a panel of experts to develop recommendations for how to best develop patient-focused assessments of health care performance. They published their findings in an article in the journal Value in Health.
UNC Lineberger team finds possible strategy to overcome radiation therapy resistance acquired by cancer cells
In a new study published in the Cell Press journal Chemistry & Biology, researchers share a discovery that they say could lead to a new strategy for sensitizing radiation-resistant cancer cells to the treatment.
Potential drug target identified for aggressive breast cancer type
In a new pre-clinical study published today, UNC Lineberger researchers show that they can exploit cancer's reliance on a particular protein to help fight triple negative breast cancer. They believe the protein could be a potential new drug target.
What a Difference a Year Makes
Veatrice Harris wasn't afraid of battling cancer. She leaned on her faith, her family, and her UNC caregivers to face the toughest year of her life. Now, thanks to an innovative procedure called a 50/50 bone marrow transplant, Veatrice has renewed hope for 2015.
UNC Lineberger researchers help map genetic mutations in skin cancer
UNC Lineberger researchers significantly contributed to a better understanding of the genetic alterations found in cutaneous melanoma as part of a multi-institution, international effort of The Cancer Genome Atlas (TCGA). Researchers collected samples from 331 patients and used several molecular methodologies to complete the study, the largest of its kind to-date for cutaneous melanoma. The findings were published in the journal Cell.
Early menarche may be important in development of aggressive breast cancer in African-American women
A multicenter research team known as the African American Breast Cancer Epidemiology and Risk Consortium (AMBER), which includes UNC Lineberger's Andrew Olshan, PhD has uncovered differences in ER-positive & ER-negative breast cancer pathways. The team examined whether relationships between age at menarche and breast cancer are the same for tumors that are ER-positive or ER-negative, particularly among African-American women. ER-negative breast cancer is generally more aggressive and known to be associated with a poorer prognosis than ER-positive disease.
Precision medicine at UNC: Looking for cancer-driving gene mutations across cancers
UNC Lineberger will be enrolling patients into a new, national clinical trial, known as NCI-MATCH, that will group patients based on the genetics of their tumors as opposed to where their cancer is located. The new initiative will test more than 20 drugs or drug combinations targeting specific genetic mutations.
Leading immune system discovery at the molecular level
Jenny Ting, PhD, a UNC Lineberger Comprehensive Cancer Center member and a William R. Kenan Jr. Distinguished Professor in the UNC School of Medicine Department of Genetics, has studied genetic and molecular mechanisms behind immune system development for more than three decades at UNC. Now she's helping to lead two major federal center grants to further vaccine development and boost our understanding of immune responses to viruses.
Assessment is first to measure breast and cervical cancer landscape in Zambia
The assessment, co-published by UNC Lineberger member and professor of gynecologic oncology Groesbeck Parham, MD, not only identifies the roadblocks to treatment, but also provides a path to overcoming them.
UNC Lineberger breast cancer researcher wins ASCO foundation grant
Katherine Reeder-Hayes, MD, MBA, Msc, a UNC Lineberger member and a clinical assistant professor in the University of North Carolina School of Medicine, won a Career Development Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology. She was one of 11 clinical investigators chosen to receive the three-year award, which goes to researcher-physicians to help them build independent clinical research programs.
A Complete Team
Nearly a year ago, thirteen-year-old Liam Canard, of Raleigh, was diagnosed with Hodgkin's lymphoma. Although his fight against the disease goes on today, he has already won by continuing to do what he loves.
UNC Lineberger cancer researchers to present findings at ASCO annual meeting
UNC Lineberger members were authors on nearly 30 abstracts that will be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago being held May 29-June 2, 2015.
The thrill of discovery
UNC Lineberger researcher Ben Major, PhD, an assistant professor in the UNC School of Medicine Department of Cell Biology and Physiology, studies cell signaling pathways in normal and cancerous cells. He hopes that a finding made by his team earlier this year could lead to a new treatment for a typically fast-growing type of lymphoma.
UNC Lineberger member to lead NCI grant to improve clinical trials for cancer patients
UNC Lineberger member Michael R. Kosorok, PhD, W.R. Kenan Jr. Distinguished Professor and chair of biostatistics at UNC's Gillings School of Global Public Health, is the contact principal investigator for an multi-institution effort to continue to find ways to develop more powerful clinical trials for cancer patients. The project is backed by a five-year, $10.4 million grant from the National Cancer Institute.
A new era for genetic interpretation
UNC Lineberger researchers are collaborating through the ClinGen consortium - a program launched to evaluate the clinical relevance of genetic variants - to help physicians make predictions about an individual's risk of disease, develop more accurate clinical trials and design individualized treatments and care for patients.
A beloved doctor inspires a continuum of compassion
The latest installment in the Family House Diaries video series features Dr. Tom Shea, the Director and Founder of UNC's Bone Marrow Transplant Program, and Joe and Veatrice Harris of Roanoke Rapids, North Carolina.
UNC fellow wins 2015 Young Investigator Award for lung cancer research
Adam Belanger, MD, a second-year fellow at UNC School of Medicine, has received the Conquer Cancer Foundation of ASCO's Young Investigator Award. The award provides research funding to promising physicians to support the transition from fellowship to faculty appointment, encourage continued interest in clinical cancer research and assist them in their careers as both physicians and researchers. Recipients will each receive a one-year grant of $50,000 to fund their studies as they begin careers in oncology research.
UNC cancer researchers honored with Conquer Cancer Foundation of ASCO Merit Awards
Emily Guerard, MD, a fellow in the UNC School of Medicine Division of Hematology/Oncology, and Stephanie Wheeler, PhD, MPH, a UNC Lineberger member and an assistant professor of health policy and management in the UNC Gillings School of Global Public Health, have been honored with 2015 Conquer Cancer Foundation of ASCO Merit Awards.
UNC Lineberger researcher, collaborators to test molecular imaging technology
A four-year grant from the National Cancer Institute will fund a pre-clinical study of molecular ultrasound imaging technology that researchers believe can better gauge whether cancer treatments are working.
Northwestern Mutual expands support for childhood cancer in North Carolina
$125,000 donation by company to fund UNC Lineberger Comprehensive Cancer Center Pediatric Oncology Retreat
Join the UNC/Rex team for 2015 Susan G. Komen Triangle Race for the Cure!
The 2015 Susan G. Komen Triangle Race for the Cure is scheduled for Saturday, June 13th on the campus of Meredith College in Raleigh, NC.
Martin Baucom named UNC Lineberger senior executive director of development and communications
In his new role as senior executive director of development and communications at UNC Lineberger, Martin Baucom will lead the organization's efforts to secure philanthropic support and expand awareness of the center to further the work of scientists and physicians who are revolutionizing cancer research and lifesaving care for the people of North Carolina.
UNC faculty author new book on engineering radiation therapy safety
Faculty in the UNC School of Medicine Department of Radiation Oncology have co-authored a new book that details initiatives launched at UNC to maximize radiation therapy safety.
Bobby Kadis: Living life to the fullest
These days Bobby Kadis is living life to the fullest. After being diagnosed with Stage 4 lung cancer, he enrolled in a UNC Lineberger clinical trial using a combination of targeted drug therapies. Now the avid potter, mountain climber and yoga enthusiast celebrates being cancer-free.
Earp receives honor from UNC-Chapel Hill Alumni Association
On Saturday, May 9, the General Alumni Association at the University of North Carolina at Chapel Hill honored Dr. H. Shelton "Shelley" Earp III, director of UNC Cancer Care and former director of the UNC Lineberger Comprehensive Cancer Center, for his outstanding service to the University and to the association.
UNC analysis shows advantage for picture-based cigarette pack warnings over text warnings
A University of North Carolina at Chapel Hill analysis published today in the journal Tobacco Control synthesized the results of 37 different experiments comparing picture-based and text warnings, finding that picture-based warnings were more effective than text warnings on 20 of 25 different outcome measures.
Partnering with IBM and Watson to accelerate DNA analysis and inform personalized treatment
UNC Lineberger will be one of more than a dozen leading cancer centers tapping IBM's Watson to accelerate DNA analysis and inform personalized treatment options for patients. The project is part of IBM's broader Watson Health initiative to advance patient-centered care and improve health.
Ellen Martin: Battling Breast Cancer with Resilience and Research
A busy mom of two, Ellen Martin battled breast cancer with two powerful weapons – resilience and research. Following an aggressive breast cancer diagnosis, Ellen is now in remission thanks to a treatment plan driven by the latest findings in breast cancer research.
UNC Lineberger members awarded 2015 UNC Health Care and Faculty Physicians Award for Carolina Care Excellence
UNC Health Care administers the CMS-approved Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) survey to solicit feedback from our patients. Many UNC Lineberger physicians received the highest-possible honors from the patients they serve.
UNC researchers create DNA repair map of the entire human genome
The new experimental assay can help scientists find the precise locations of repair of DNA damage caused by UV radiation and common chemotherapies. The invention could lead to better cancer drugs or improvements in the potency of existing ones.
UNC Lineberger study finds new potential melanoma drug target
A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Cancer Research, the authors report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
A BRAIN Initiative first: new tool can switch behavior 'on' and 'off'
Using a new 'chemogenetic' technique invented at UNC, scientists turn neurons 'on' and 'off' to demonstrate how brain circuits control behavior in mice. This unique tool – the first to result from the NIH BRAIN Initiative – will help scientists understand how to modulate neurons to more effectively treat diseases.
Roger Johnson: Thankful for every day
Siler City native Roger Johnson knows the value of personalized medicine. After being diagnosed with bladder cancer in 2013, physicians at UNC sequenced his tumor to better understand the genetics driving his cancer.
Eligible for breast conserving therapy, many still choose mastectomy
New treatment strategies have given more triple-negative breast cancer patients the choice of breast-conserving surgery. But research led by Brigham and Women's Hospital, in collaboration with UNC Lineberger member David Ollila, MD, has shown that even when given the choice, more than 30 percent of patients still chose to have a complete breast removal via mastectomy.
Der pulls in two grants for pancreatic cancer research
The Pancreatic Cancer Action Network and the American Association for Cancer Research announced April 16 that UNC Lineberger's Channing Der, PhD, and two co-principal investigators were chosen to receive a $1 million grant for pancreatic cancer research. Earlier this year, Der was also announced as the recipient of a grant from The Lustgarten Foundation, the nation's largest private funder of pancreatic cancer research.
Yeh elected to American Society for Clinical Investigation
UNC Lineberger's Jen Jen Yeh, MD, has been elected to the American Society for Clinical Investigation, an honor society for physician-researchers. A formal induction ceremony was held April 24 at the joint ASCI/AAP meeting in Chicago.
Clinical Research Forum selects genomic analysis as top 10 research achievement
A cancer genomics study led by UNC Lineberger researchers and other scientists involved in The Cancer Genome Atlas (TCGA) project, a National Cancer Institute and National Human Genome Research Institute-backed effort to create a comprehensive atlas of the genetic changes in cancer, was selected as one of the top 10 clinical research achievements of the year. The project characterized molecular changes in 12 different cancers and revealed a new approach to classifying cancers.
With Grace and Good Humor
Fifteen years ago, Nancy Raasch was diagnosed with metastatic breast cancer. Then, in 2009, came multiple myeloma. Despite these malignancies, she refuses to let cancer define her.
UNC Lineberger-led report details strategies for including patient-reported outcomes in cancer drug labeling
A UNC Lineberger-led report published online in JAMA Oncology describes barriers to getting patient-reported outcomes information into cancer trials and drug labels in the United States as well as recommendations for overcoming those obstacles.
Stupid Cancer visits UNC Lineberger as part of nationwide road trip
Stupid Cancer, a nonprofit organization focused on young adult cancer awareness, visited the N.C. Cancer Hospital on April 11 as part of its nationwide advocacy tour. The Stupid Cancer Road Trip is a grassroots campaign aiming to increase awareness of young adult cancer throughout the country. While stopping in major U.S. cities, Kenny Kane and John Sabia tour cancer centers, host special events and get to know the local cancer communities.
Hatchell, supporters prepare blueberry patch supporting UNC Lineberger
On Saturday, April 11, UNC Women's Basketball Coach Sylvia R. Hatchell hosted a UNC Lineberger Comprehensive Cancer Center Blueberry Patch "work day" at her land in the North Carolina mountains, located between Black Mountain and Fairview.
UNC Lineberger members to share research, expertise at 2015 AACR meeting
UNC Lineberger Comprehensive Cancer Center researchers will share their study findings and expertise at the American Association for Cancer Research's annual meeting, which is expected to draw thousands to Philadelphia April 18-22 to discuss advances in cancer science.
Cancer genetics the focus of UNC Lineberger symposium
UNC Lineberger's 39th annual scientific symposium was held April 8-9 at the William and Ida Friday Center for Continuing Education in Chapel Hill.
Researchers find new approach to treat drug-resistant HER2-positive breast cancer
Using human cancer cell lines, UNC scientists identified various ways that HER2-positive breast cancer tumors resist therapy, and they discovered a potential combination therapy to overcome multiple mechanisms of resistance and kill cancer cells.
Lower survival rates connected with high-risk melanoma with mutations, study finds
A UNC Lineberger-led study found that people with higher-risk melanoma containing either BRAF or NRAS gene mutations had lower survival rates.
Price of cancer drugs varies widely based on who's paying, study finds
Medicare recipients, private insurance patients and the uninsured all pay different prices for the same cancer treatments
UNC Lineberger sequences 10,000 tumors as part of national cancer genomics effort
UNC sequenced the RNA for 10,000 tumor samples as part of The Cancer Genome Atlas project, a National Cancer Institute and National Human Genome Research Institute-backed effort to create a comprehensive atlas of the genetic changes in cancer.
UNC-TV broadcasts feature UNC doctors, Lineberger's cancer survivorship director
To lead into segments of PBS' three-part series "Cancer: The Emperor of All Maladies," UNC-TV planned broadcasts featuring health care providers from UNC.
UNC Lineberger-led study tests drug strategy for aggressive breast cancer in the brain
Results from a UNC Lineberger-led study were published Monday in the journal Molecular Cancer Therapeutics. The pre-clinical study was the first to investigate one particular drug strategy as a treatment for breast cancer after it's spread to the brain.
Mayer recognized by Oncology Nursing Society
The UNC Lineberger Comprehensive Cancer Center's Director of Cancer Survivorship Deborah K. Mayer, PhD, RN, has been recognized for her commitment to the Oncology Nursing Society and to the community as a whole.
New UNC Lineberger faculty recruited to launch T-cell cancer therapy trials
Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials that will test an experimental treatment in which patients' own immune cells are genetically engineered to fight their cancer.
Researchers explore roots of breast cancer disparities at symposium
A symposium co-sponsored by the UNC Lineberger Comprehensive Cancer Center brought leading breast cancer researchers together Friday to share findings about the genetic and environmental factors driving disparities in the disease's incidence and mortality.
UNC Lineberger researchers to study prostate cancer treatment side effects, survival outcomes
The use of robot-assisted surgery and modern radiation techniques have been rapidly adopted as treatments for prostate cancer, but a UNC Lineberger Comprehensive Cancer Center researcher is asking what the newer technologies will mean in terms of side effects and outcomes for patients in the long-term.
Perou recognized as health care innovator, awarded Triangle Business Journal honor
Charles M. Perou, PhD, professor of genetics and pathology at the University of North Carolina School of Medicine and the basic science leader of the UNC Lineberger Comprehensive Cancer Center Breast Cancer Research Program, has been acknowledged as a health care innovator by the Triangle Business Journal. During an awards ceremony on Thursday, Perou was selected from a pool of candidates as the finalist in the 2015 TBJ Health Care Heroes – Innovator category.
Melissa Troester, PhD – Team Science at its Best
UNC Lineberger member Melissa Troester, PhD, values a team approach in her work and her personal life. As co-leader of the cancer center's Cancer Epidemiology Program, Troester's work is an important part of UNC Lineberger's interdisciplinary research on the causes of breast cancer and the translational research on strategies of prevention, treatment and cure.
NC Cancer Hospital hosts 'Strollin' Colon' to raise colorectal cancer awareness
While studies have shown that the colonoscopy can reduce the risk of death from colorectal cancer, researchers have also shown that not all people recommended for the test actually get it. To help inform people about colorectal cancer risks and symptoms as well as the benefits of screening, the N.C. Cancer Hospital hosted a public outreach event last Thursday and Friday.
UNC Lineberger's Muss honored as exemplary cancer caregiver
The American Cancer Society has honored Hyman B. Muss, MD, director of the UNC Lineberger Comprehensive Cancer Center Geriatric Oncology Program, with a prestigious national award that recognizes providers who show compassion and dedication beyond the call of duty.
Few online e-cigarette vendors block sales to minors, UNC Lineberger study finds
A study led by a UNC Lineberger Comprehensive Cancer Center researcher has found that, despite a North Carolina law banning their purchase by minors and requiring online vendors to verify customer age, teens can easily buy electronic cigarettes online.
Rising thyroid cancer rate linked to more testing, UNC-led study finds
A dramatic increase in the thyroid cancer rate across the last 30 years has researchers asking whether the disease's incidence is truly on the rise, or if improved detection methods are behind the trend.
UNC researchers study tobacco cessation needs from patient perspective
Seeking the patient voice early in the cessation process is critical to success.
UNC Lineberger-led study builds understanding of hepatitis C virus replication
Hepatitis C virus infection is a common cause of liver disease and of liver cancer in the United States. Through a new study that explores one aspect of how the virus hijacks host cell machinery to replicate itself, UNC Lineberger Comprehensive Cancer Center researchers have gained insight into the workings of a potential drug target for hepatitis C.
Cancer Support Program opens survey for parents with advanced cancer
The UNC Lineberger Comprehensive Cancer Support Program (CCSP) is now recruiting patients for a new online survey-based research study on the experiences of parents living with advanced cancer.
UNC's multidisciplinary melanoma conference draws health professionals from around NC
The ninth annual UNC Multidisciplinary Melanoma Conference brought more than 120 health care professionals from across the state on Thursday, February 12 to learn about the detection and treatment of melanoma.
Cancer Survivor Becomes Ambassador for Hope
The latest installment in UNC Health Care's Real Medicine video series features Ashley Burnette, 11-year-old cancer survivor and Patient Ambassador at the North Carolina Children's Hospital.
Sleep for Cells
With new funding, a UNC startup is poised to halt the most devastating effects of chemotherapy.
Tennis star Isner hosts fifth annual tennis exhibition benefiting UNC Lineberger
To give back to an institution that he credits with saving his mother's life, America's top-ranked men's singles tennis player John Isner returned to his hometown of Greensboro on Saturday, February 7th for his annual tennis exhibition event.
Smith awarded funding to identify research topics that matter most to patients
UNC Lineberger's Smith was awarded a contract by the Patient-Centered Outcomes Research Institute to find the research questions that matter most to bladder cancer patients.
A soft hat – and a tender heart
Most 12 year olds collect Pokemon or baseball cards. But, for 7th grader Gray Garber, it's hats. And not just any hats. Hats that are fun, happy and perfectly soft on the inside – soft enough for the delicate heads of pediatric cancer patients at the N.C. Cancer Hospital.
UNC-Chapel Hill spinout secures $33 million investment to advance novel cancer treatments
One of nation's top universities yields more than 150 startup companies to date, including G1 Therapeutics, creating jobs and advancing innovation and entrepreneurship.
Potential pancreatic cancer treatment could increase life expectancy
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients.
UNC Lineberger analysis finds that advanced age should not limit cancer treatment
After comparing the survival outcomes of older and younger people with head and neck cancer, UNC Lineberger researchers have found that age alone shouldn't dictate a patient's treatment. The findings were published January 12 online in the journal The Oncologist.
UNC Board of Trustees chair and cancer survivor Lowry Caudill headlines 28th Annual Lineberger Club event
Nearly 300 UNC Lineberger Comprehensive Cancer Center supporters gathered at the Carolina Inn to hear the remarks of distinguished UNC alumnus Lowry Caudill, PhD, on January 24, 2015 during the 28th Annual Lineberger Club Lunch and Basketball Game.
Basch calls for more data on prostate cancer detection technology in JAMA editorial
A UNC Lineberger researcher has pointed to a need for more data on whether new technology designed to better detect men at higher-risk for prostate cancer will also mean improvements in survival rates and symptoms.
Her First Thought
When a young woman receives a cancer diagnosis, her obvious first thought is "I want to survive this." When that cancer diagnosis has an impact on her ability to have children, she has a second thought.
UNC researcher co-leads effort to map genomic changes in head and neck cancer
A study co-led by a UNC Lineberger Comprehensive Cancer Center researcher has identified genomic changes in head and neck cancers linked to the sexually transmitted disease HPV -- the latest finding of a collaborative scientific effort designed to map out the genomic changes driving cancer.
Researchers pinpoint two genes that trigger severest form of ovarian cancer
UNC geneticists create the first mouse model of ovarian clear cell carcinoma; show how a known drug can suppress tumor growth.
Hoadley and Perou research featured in ASCO annual review
Research led by UNC Lineberger Comprehensive Cancer Center members Katherine Hoadley, PhD, research assistant professor in genetics and Chuck Perou, PhD, professor of genetics and pathology, was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2015, the Society's annual review of progress against cancer and emerging trends in the field. The study, a comprehensive tumor genetic analysis which revealed a new way of classifying cancers, is featured as one of the year's major achievements in clinical cancer research and care.
Gershon, Gama named 2015 recipients of Weatherspoon Family Brain Tumor Research Award
Timothy R. Gershon, MD, PhD, and Vivian Gama, PhD, have been announced as the 2015 recipients of the Weatherspoon Family Brain Tumor Research Award.
Breast cancer prevention drug benefit varies among at-risk women, study finds
After weighing the risk of serious side effects with the benefits of a breast cancer prevention drug, a study led by a University of North Carolina at Chapel Hill researcher found that the drug's benefits outweighed risks for most, but not all women.
Emily's gifts
Eight year old Emily McCann of Apex came to the N.C. Cancer Hospital at the end of December bearing gifts. She brought money to help meet the needs of pediatric cancer patients, but she also brought cheer, comfort and hope.
Tumor microenvironment is a rough neighborhood for nanoparticle cancer drugs
Researchers look at area around tumors to help personalize treatment for triple-negative breast cancer
Statewide network established to support cancer survivors
The Duke Endowment awards $461,750 grant to UNC Lineberger's Comprehensive Cancer Support Program.
John Isner's Ebix Charity Challenge to feature Bryan Brothers, benefit UNC Lineberger
Ebix, Inc., today announced that the annual Ebix Charity Challenge, will be held in Greensboro, North Carolina on February 7, 2015. All proceeds from the 5th Annual Ebix Charity Challenge will benefit the UNC Lineberger Comprehensive Cancer Center, where America No. 1 John Isner's mother, Karen, was successfully treated during her two battles with colon cancer.
Priceless Gem
Carolina legend Danny Talbott performed at the highest level on both the football field and baseball diamond during his years as a Tar Heel. Since 2010, he's been back in Chapel Hill, battling the toughest opponent he's faced: multiple myeloma. He can't imagine going anywhere else to do it.
2014 by the numbers
2014 was an exciting year for UNC Lineberger. Check out this graphic that shows what amazing progress you helped us make over the last 12 months - by the numbers.
Evans co-authors commentary in JAMA
UNC Lineberger Comprehensive Cancer Center member Jim Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine and director of clinical cancer genetics, has co-authored a commentary on proposed US Food and Drug Administration (FDA) regulation of genetic testing in the Journal of the American Medical Association (JAMA).
Beating cancer shouldn't mean the end of care
Deborah Mayer, Ph.D., R.N., AOCN, FAAN, Professor at the School of Nursing, Director of Cancer Survivorship at UNC Lineberger, is a national pioneer on research in cancer survivorship. Her work sheds light on the best ways to monitor and manage care for cancer survivors long after diagnosis and treatment. She is a staunch advocate for serving patients' needs and the importance of good communication.
UNC Lineberger hosts Kidney Cancer Association Patient and Survivor Conference
UNC Lineberger Comprehensive Cancer Center hosted the Kidney Cancer Association Patient and Survivor Conference at the William & Ida Friday Center for Continuing Education on Saturday, December 13, 2014. Attendees from New Jersey, Maryland, West Virginia, Virginia, South Carolina and North Carolina gathered to hear presentations on topics such as managing treatment, new therapies and navigating the health care system.
Pecot named one of only two ACS Mentored Research Scholar awardees
Chad Pecot, MD, assistant professor in hematology and oncology, has received a Mentored Research Scholar Award in Applied and Clinical Research from the American Cancer Society (ACS). Dr. Pecot is one of only two recipients in the United States to receive the award.
Free legal help for those who need it most
The UNC Cancer Pro Bono Project allows law students, working under the supervision of volunteer attorneys, to draw up advance directives for cancer patients, for free. Originally designed as a joint program with Duke, Carolina's student-run program has grown so much that it operates independently now, with the help of Legal Aid of North Carolina Inc. and about 35 volunteer attorneys.
UNC Lineberger members present at 2014 San Antonio Breast Cancer Symposium
UNC Lineberger members Lisa Carey, MD, Chuck Perou, PhD, Hyman Muss, MD, Carey Anders, MD, and Katherine Hoadley, PhD will present at leading breast cancer research symposium.
N.C. Cancer Hospital nurse selected as recipient of national leadership award
AnnMarie Walton, MPH, RN, OCN, CHES, PhD candidate, an oncology nurse at the N.C. Cancer Hospital, who has made extraordinary efforts to improve the health and lives of agricultural workers and health care providers has been recognized as one of the 10 recipients of the new Breakthrough Leaders in Nursing award created by the Future of Nursing: Campaign for Action, a joint initiative of AARP and the Robert Wood Johnson Foundation.
UNC Lineberger members presenting at the American Society of Hematology Annual Meeting
Several UNC Lineberger members and UNC School of Medicine faculty presented at the American Society of Hematology (ASH) Annual Meeting in San Francisco last week. With more than 15,000 members from nearly 100 countries, ASH is the world's largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases. The 56th ASH Annual Meeting & Exposition is the premier event in malignant and non-malignant hematology.
Carey named newly elected member of ASCO Nominating Committee
Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, has been named to the American Society of Clinical Oncology (ASCO) Nominating Committee. An ASCO member since 1997, Carey will serve a three-year term on the committee.
Hats for Hope Charli' Ramsey Hat Drive benefits patients at the N.C. Cancer Hospital
Since 2009, Elizabeth Stewart has honored the memory of her daughter Charli' Ramsey with an annual hat drive for pediatric oncology patients and bone marrow transplant patients at UNC Lineberger. Charli' was treated for leukemia at UNC before she passed away in 2001 at the age of nine. Over the years, the effort has expanded to include not just hats but pillowcases, blankets and scarves: all items that provide comfort and a measure of happiness to patients in treatment.
UNC researchers pinpoint chemo effect on brain cells
UNC Lineberger members and UNC School of Medicine researchers have found for the first time a biochemical mechanism that could be a cause of "chemo brain" – the neurological side effects such as memory loss, confusion, difficulty thinking, and trouble concentrating that many cancer patients experience while on chemotherapy to treat tumors in other parts of the body.
Ewend receives Fuller Award
Matthew G. Ewend, MD, FACS, Van L. Weatherspoon, Jr. Eminent Distinguished Professor and Chair, UNC Department of Neurosurgery and UNC Lineberger member, has been awarded this year's H. Fleming Fuller Award.
Honoring excellence in oncology nursing and clinical services
Congratulations to nurse practitioner Mary Dunn and clinical nurse Lauren Terzo for winning the 2014 Oncology Nursing Excellence Award and to financial counselor Cynthia Moody and administrative support supervisor Christine Nadel, winners of the 2014 Clinical Services Excellence Award.
Cancer and Older Adults forum held at Friday Center
Over 100 people had the opportunity to learn about cancer, aging and resilience from UNC cancer care experts on Friday, November 14, at Cancer Care and Older Adults: A Public Forum hosted by UNC Lineberger Comprehensive Cancer Center.
UNC researchers create new technique to silence leading cancer-causing gene
UNC Lineberger researchers and colleagues at The University of Texas MD Anderson Cancer Center have developed a new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer. The approach, led by Chad Pecot, MD, an assistant professor of medicine at UNC, offers another route to attack KRAS, which has proven to be an elusive and frustrating target for drug developers.
Moschos named one of 11 NCI Cancer Clinical Investigator Team Leadership Awardees
Stergios Moschos, MD, associate professor and UNC Lineberger Comprehensive Cancer Center member, is among 11 physicians from across the country to receive the National Cancer Institute (NCI) 2014 Cancer Clinical Investigator Team Leadership Award.
HPV vaccine uptake among girls is lowest in states with highest rates of cervical cancer
The proportion of adolescent girls receiving human papillomavirus (HPV) vaccines was much lower in states with higher rates of cervical cancer incidence and mortality, according to data presented by doctoral student Jennifer Moss at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 9–12.
Nichols awarded $200,000 Avon grant to study pregnancy-associated breast cancer
The 12th annual Avon Walk for Breast Cancer season concluded with the Charlotte Walk on October 26, raising $1.4 million to accelerate breast cancer research and improve access to screening, diagnosis, treatment and education. Hazel Nichols, PhD, assistant professor epidemiology at UNC Gillings School of Global Public Health is leading one of five teams in the Carolinas awarded a grant of $200,000 to support a study that will analyze data from 18 ongoing studies on pregnancy-associated breast cancer.
Pecot named V Scholar
Chad Pecot, MD, assistant professor in hematology and oncology, has received a V Scholar Award from the The V Foundation for Cancer Research. Dr. Pecot is one of 20 recipients in the United States to receive the two-year $200,000 award.
Coghill awarded translational research grant from the Leukemia & Lymphoma Society
Targeting CC-Chemokine Receptor 7 (CCR7) with fully human anti-CCR7 antibodies for the prevention of graft-versus-host disease.
UNC Urology kicks off 3rd Annual UNC Movember Campaign
The UNC Department of Urology is once again participating in Movember, a global mustache-growing fundraising campaign meant to spark conversation and raise funds for men's health programs.
UNC Health Registry hits enrollment milestone
Over 5,000 cancer patients are now enrolled in the UNC Health Registry, an initiative funded by the University Cancer Research Fund established to better understand the long-term consequences of cancer, which affect many North Carolinians. This milestone hits the half-way mark of the 10,000 enrollment goal.
Kicking off Lung Cancer Awareness Month at the LUNGe Forward 5K
UNC Cancer Care thoracic oncologists joined the Lung Cancer Initiative's Raleigh LUNGe Forward 5K Run, Walk & Rally on November 1, 2014 in Raleigh, NC.
UNC research trio teams up to fight cancer drug resistance
The V Foundation awards $600,000 grant to UNC Lineberger to track kinase activity in head and neck, lung and esophageal cancers.
Drug discovery center draws on UNC bench science
When Stephen Frye completed his Ph.D. in chemistry at Carolina in 1987, he set out to make a difference.
UNC Lineberger researchers present at international breast cancer conference in Saudi Arabia
Three UNC Lineberger members - Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, Matt Ewend, MD, Van L. Weatherspoon Jr. Distinguished Professor of Neurosurgery and chair of the UNC Department of Neurosurgery, and Chuck Perou, PhD, professor of genetics and pathology – served as speakers at the 6th Annual Princess Noorah Oncology Center International Breast Cancer Conference held in Jeddah.
Partnerships, cancer research in Malawi to expand with new grant
UNC Lineberger Comprehensive Cancer Center and the UNC Institute for Global Health & Infectious Diseases have received a $3.7 million grant from the National Cancer Institute (NCI) to study the growing worldwide cancer problem and expand the University's efforts in Malawi to study and treat HIV-associated cancers.
Kicking cancer to the curb!
SOCCER.COM, the world's leading authentic grassroots soccer company, is helping kick cancer to the curb!
UNC scientists discover hidden subpopulation of melanoma cells
The research, led by Andrew C. Dudley, has implications for developing cancer drugs that target blood vessels that feed tumors.
Meyer named faculty director of ICISS
UNC Lineberger Comprehensive Cancer Center member, Anne-Marie Meyer, PhD, assistant professor of cancer epidemiology, has been named faculty director of the Integrated Cancer Information and Surveillance System (ICISS).
Sylvia Hatchell speaks at 6th Annual UNC Coping with Cancer Symposium
UNC Women's Basketball Coach Sylvia Hatchell was one of the keynote speakers at UNC Lineberger's 6th annual Coping with Cancer Symposium on Friday, October 10. The event was well attended by health care providers and administrators from across North Carolina.
DeSimone elected to all three branches of the National Academies
Dr. Joseph DeSimone, Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and UNC Lineberger member, has been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine a U. S. scientist can receive.
Having dependent children motivates advanced cancer patients to pursue more aggressive care
A pilot study of people with advanced cancer indicates that parental status is an important factor in treatment decision-making, with the majority stating that being a parent motivates them to pursue life-extending treatments, according to research presented this week at ASCO's 2014 Quality Care Symposium by Devon Check, a Ph.D. student at the University of North Carolina at Chapel Hill.
New Template for Survivorship Care Plans Released
Deborah K. Mayer, PhD, RN, professor in the UNC School of Nursing and director of cancer survivorship at UNC Lineberger, leads national efforts to address growing need for post-treatment planning for cancer patients.
Endeavors: Just Add Liver
A tale of viruses, stem cells, and global health
Inaugural She ROCKS luncheon raises funds for ovarian cancer
The first annual She ROCKS (Research, Ovarian, Cancer, Knowledge, Support) event held recently in Wilmington raised funds that will go directly towards ovarian cancer research based at UNC Lineberger Comprehensive Cancer Center.
All the Cell's a Stage
Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.
New website launched to help women learn about risk factors for breast cancer
The UNC Breast Cancer and the Environment Research Program (BCERP) has announced the official launch of myBCrisk.org, an interactive website designed to increase knowledge about breast cancer risk factors, especially among young African-American women.
Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer
Now in its 10th year, this annual event hosted by Coach Roy Williams raised $213,000 for cancer research and treatment at UNC Lineberger Comprehensive Cancer Center.
Milowsky appointed medical director of the N.C. Cancer Hospital
CHAPEL HILL, NC – Matthew Milowsky, MD, associate professor and co-director of the Urologic Oncology Program at UNC Lineberger Comprehensive Cancer Center, has been appointed as the clinic medical director of the N.C. Cancer Hospital.
Komen awards more than $875,000 to UNC Lineberger researchers
Susan G. Komen® has awarded over $875,000 in research funding to UNC Lineberger Comprehensive Cancer Center.
Team UNC Oncology among top fundraising teams for Light The Night Walk
The Leukemia & Lymphoma Society (LLS) held their Light The Night Walk at Rock Quarry Park in Durham on Saturday, September 20. The evening fundraising walk celebrated and commemorated lives touched by blood cancer. More than a walk, the evening had a carnival atmosphere and included refreshments, entertainment, music and kids' activities
UNC Lineberger hosts Metastatic Breast Cancer Network Conference
The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.
Nielsen named Director of UNC Urologic Oncology
Matthew Nielsen, MD, MS, assistant professor of urology and adjunct assistant professor of epidemiology and health policy & management, has been named director of urologic oncology in the UNC Department of Urology. In his new role, he joins Matthew Milowsky, MD, associate professor of medicine, as co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital.
Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception
On September 24, 2014, UNC Lineberger held a reception to honor Dr. Sharon Campbell, recipient of the 2014 Hyman L. Battle Distinguished Cancer Research Award.
The Geneticist
With his selection to the NIH Council of Councils, Terry Magnuson, PhD, becomes the first UNC scientist appointed to the board dedicated to funding the biggest ideas in medical research.
UNC researchers find final pieces to the circadian clock puzzle
Sixteen years after scientists found the genes that control the circadian clock in all cells, the lab of UNC's Aziz Sancar, MD, PhD, discovered the mechanisms responsible for keeping the clock in sync.
Damania appointed Assistant Dean for Research
Blossom Damania, PhD, professor of microbiology and immunology, has been named Assistant Dean for Research at the UNC School of Medicine, effective immediately.
Basch contributes to new ASCO guidelines for prostate cancer treatment
New clinical guidelines have been announced for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). Ethan Basch, MD, director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, served as the co-chair of the ASCO/CCO expert panel that developed the guideline.
UNC researchers find new genetic target for a different kind of cancer drug
Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.
Popular cancer drug target implicated in cardiovascular defects
Research led by UNC's Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development
Reporting back (Spoiler: it's awesome news!)
Thanks to you, 2013-14 was a big year for UNC Lineberger.
Changing the face of clinical trials
UNC Lineberger secures three major NCI grants to advance the nation's clinical trials program.
Anders presents at 13th Annual Round Asia Oncology Forum
Carey Anders, MD, UNC Lineberger member and associate professor, was a presenter and moderator at The 13th Annual Round Asia Oncology Forum (RAOF) in Hong Kong on August 29 - 30, 2014. The theme of this year's forum was "Expanding our armory in personalized cancer treatment."
Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery
The UNC Eshelman School of Pharmacy has received a $3 million gift from philanthropist and pharmaceutical-industry executive Fred Eshelman. Eshelman's gift will support the work of the School's Center for Integrative Chemical Biology and Drug Discovery, led by UNC Lineberger member Stephen Frye, PhD. The center is dedicated to evaluating and developing potential drug targets discovered by UNC faculty.
2014 University Cancer Research Fund Innovation Awards announced
Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.
Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund
UNC Health Care and Rex Healthcare co-sponsored "Field of Hope" at the Durham Bulls game on Saturday, August 23 with a portion of special ticket sales going to the Kay Yow Cancer Fund.
Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit
The Lung Cancer Initiative of NC hosted a statewide Lung Cancer Summit on August 23 at the N.C. Cancer Hospital. Lung cancer advocates were bolstered with training, resources, knowledge and the courage to take action. UNC Lineberger Comprehensive Cancer Center was the Host Sponsor of the event.
The Ras Tracker
For more than 20 years, Sharon Campbell, PhD, has been studying Ras, a protein implicated in 30 percent of all cancers. Now she's on the hunt for alternative ways to shut the protein down.
UNC researchers trade lab coats for running shoes
Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.
UNC Lineberger researchers develop new approach to identify "drivers" of cancer
UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic "drivers" of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy. The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.
$150,000 Childhood Cancer Research Grant Awarded to the University of North Carolina at Chapel Hill
Part of More Than $24.7 Million Awarded in New Grants by the St. Baldrick's Foundation
UNC researchers lead project to sequence rare kidney cancer
An international scientific collaboration led by researchers at UNC has revealed new insights into the unique genetic alterations that contribute to a rare form of kidney cancer.
Older Patients with Limited Life Expectancy Still Receive Cancer Screenings
A substantial number of older patients with limited life expectancy receive routine screenings for prostate, breast, cervical and colorectal cancer even though the procedures are unlikely to benefit them, according to research conducted at the University of North Carolina at Chapel Hill.
UNC Lineberger announces Developmental Research Award winners
UNC Lineberger Comprehensive Cancer Center has awarded nine researchers with Developmental Research Awards to support their work in advancing the fields of clinical/translational and population science cancer research.
UNC Cancer Care's statewide multidisciplinary approach highlighted in Health Leaders Media
A recent article published in the July/August 2014 issue of Health Leaders magazine focuses on some of UNC Lineberger's strengths that rank it among the nation's leading cancer centers.
U.S. News article highlights nation's top cancer centers, cites UNC Lineberger
A recent U.S. News & World Report article highlights the nation's cancer centers, focusing especially on those that the National Cancer Institute has designated as comprehensive cancer centers, citing advantages of patients being seen at or referred to these sites, including advances in technology and collaboration.
Largest cancer genetic analysis reveals new way of classifying cancer
Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill and other TCGA sites, not only revamps traditional ideas of how cancers are diagnosed and treated, but could also have a profound impact on the future landscape of drug development.
Genetic mutations linked to salivary gland tumors may point to new therapies
Faculty members at the University of North Carolina School of Dentistry, The Scripps Research Institute (TSRI) and other institutions have discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands. The discovery could help physicians develop new treatments that target the cancer's underlying genetic causes.
Remembering Dr. Feng Liu
Feng Liu, PhD, a research professor in the Division of Molecular Pharmaceutics and UNC Lineberger member, died tragically Thursday, July 24, after being assaulted and robbed while walking in a neighborhood near campus. Liu was a dedicated colleague, educator and researcher focused on gene and drug delivery.
UNC researchers discover how Hepatitis C virus persists for years
Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.
UNC jumps 5 slots in 2014–15 U.S. News & World Report cancer rankings
UNC Hospitals is nationally ranked in cancer, taking the number 38th spot in the country. The latest ranking is up from 43rd in 2013.
Amelio joins UNC School of Dentistry, UNC Lineberger
Dr. Antonio (Tony) Amelio recently began his joint appointment as assistant professor in the Department of Dental Ecology at the UNC School of Dentistry and as associate member at UNC Lineberger.
Campbell awarded 2014 Battle Cancer Research Award
Sharon Campbell, professor of biochemistry and biophysics, has been awarded the 2014 Hyman L. Battle Distinguished Cancer Research Award by the UNC School of Medicine. The award recognizes sustained, exceptional cancer research over a career by School of Medicine faculty.
Three chosen as 2014 John William Pope Clinical Fellows
Three physician-scientists from the UNC Lineberger Comprehensive Cancer Center have been chosen as the 2014 John William Pope Clinical Fellows.
Kim receives 2014 Bladder Cancer Research Innovation Award
The Bladder Cancer Advocacy Network (BCAN) has awarded William Kim, MD, associate professor of medicine, urology, and genetics, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with the 2014 Bladder Cancer Research Innovation Award to support his project "Immune Characterization of High-Grade Bladder Cancer."
UNC Lineberger researchers recognized by Thomson-Reuters as highly influential
Six UNC Lineberger members are among the most often-cited scientists in the world, according to the Thomson Reuters 2014 Highly Cited Researchers list.
N.C. Medical Journal July/August issue highlights UNC Lineberger cancer research
Cancer care in North Carolina is the focus of the July/August issue of the North Carolina Medical Journal (NCMJ). The issue, co-guest-edited by UNC Lineberger Comprehensive Cancer Center members Ethan Basch, MD, and Stephanie Wheeler, PhD, MPH, features articles on a wide variety of issues that determine how the state's residents receive treatment for cancer.
Study in mice finds weight loss reduces progression of basal-like breast cancer
Obesity, epidemic in the U.S. and worldwide, is one of the important modifiable risk factors for breast cancer, especially a particularly aggressive subtype called basal-like breast cancer (BBC). Population studies have suggested that lifestyle interventions, including weight loss, could prevent a large proportion of this type of cancer; however, data on the effect of weight loss on BBC risk are limited and the mechanisms involved uncertain.
Doctors not adequately informing patients of cancer screening pros and cons, study finds
Though cancer screening has come a long way, physicians still do not thoroughly discuss with patients the advantages and disadvantages of these procedures before decisions are made to undergo the screenings, according to a new study co-authored by a physician from The University of North Carolina at Chapel Hill's Gillings School of Global Public Health.
UNC-developed tools improve accuracy of cancer DNA sequencing
The ability of researchers and physicians to use DNA sequencing to pinpoint the genetic mutations that cause cancer has led to greater understanding of the causes of the disease and development of drugs that treat tumors by targeting specific mutations. A pair of papers published by researchers at the UNC Lineberger Comprehensive Cancer Center reveal new tools that can improve the accuracy of tumor sequencing.
Chen chosen for ASCO Leadership Development Program
The American Society of Clinical Oncology (ASCO) has chosen Ronald Chen, MD, MPH, assistant professor of radiation oncology and member of the UNC Lineberger Comprehensive Cancer Center, as a member of the 2014-2015 ASCO Leadership Development Program.
WRAL story highlights bladder cancer vaccine study at UNC
A story that ran on Raleigh-based CBS affiliate WRAL focuses on a new bladder cancer vaccine being studied at UNC, called Impact Therapy. The vaccine works to target cancer cells with minimal side effects.
Shared decision making still lacking for cancer screening
NEW YORK (Reuters Health) - When it comes to cancer screening, doctors often do not adequately discuss the balance of pros and cons with their patients, a new study suggests.
Indian delegation tours UNC Lineberger
A delegation from the Tata Memorial Centre cancer hospital in Mumbai, India visited the UNC Lineberger Comprehensive Cancer Center as part of a U.S. tour visiting comprehensive cancer centers. The visit, sponsored through the National Cancer Institute's (NCI) Liaison for International Partnerships, was intended to share knowledge about how American universities and hospitals operate a comprehensive cancer center.
BB&T "Comfort Cart" comes with care
Close to a dozen BB&T employees recently gave their morning to volunteer at the Patient and Family Resource Center (PFRC) at the N.C. Cancer Hospital. They came to deliver the BB&T "Comfort Cart," a rolling cart filled with snacks to comfort and sustain cancer patients and their families while they are at the cancer hospital. They brought enough granola bars, nutrition shakes and other non-perishable snacks to keep the cart stocked for months. They also brought the gifts of housekeeping and organization.
UNC/Rex team up for 2014 Susan G. Komen Triangle Race for the Cure
The UNC/Rex team joined thousands of cancer survivors and supporters on Saturday, June 14th for the 18th annual Susan G. Komen Triangle Race for the Cure at Meredith College in Raleigh.
Vanderwalde awarded Conquer Cancer Foundation Young Investigator Award
Noam Vanderwalde, MD, a radiation oncology resident at the N.C. Cancer Hospital, was awarded a 2014 Young Investigator Award by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO).
UNC researchers pinpoint new role for enzyme in DNA repair, kidney cancer
The discovery, from the lab of Brian Strahl, PhD, offers insights for the creation of better, more targeted therapies for various forms of cancer.
Most Breast Cancer Patients May Not Be Getting Enough Exercise
Physical activity after breast cancer diagnosis has been linked with prolonged survival and improved quality of life, but most participants in a large breast cancer study did not meet national physical activity guidelines after they were diagnosed.
Wheeler and Reeder-Hayes research shows African-American women and those insured by Medicaid less likely to receive endocrine therapy to prevent breast cancer recurrence
New research by Stephanie B. Wheeler, PhD; Katie Reeder-Hayes, MD; and Anne Marie Meyer, PhD, reveals that breast cancer patients insured by Medicaid and African-American breast cancer patients are less likely to receive life-saving endocrine therapy (ET) to prevent cancer recurrence.
UNC Lineberger members present at 2014 ASCO Annual Meeting
More than 25 members and affiliated physicians of the UNC Lineberger Comprehensive Cancer Center will present their work to the attendees at the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, being held May 30 through June 3. The annual meeting brings together more than 25,000 oncology professionals to present research and discuss new treatment options.
Toxins in the Environment Might Make You Older Than Your Years
CHAPEL HILL, NC - Why are some 75-year-olds downright spry while others can barely get around? Part of the explanation, according to research published today in Cell Press journal "Trends in Molecular Medicine," is differences from one person to the next in exposure to harmful substances in the environment, chemicals such as benzene, cigarette smoke, and even stress.
2013-2014 University Cancer Research Fund Annual Report now available
The UCRF, a $42 million, state-appropriated fund established in 2007, continues to have a significant impact on cancer research in North Carolina.
Marie's 'Hike For a Cure' brings in over $5,000 for bone cancer research at UNC Lineberger
Virginia resident Marie Clem loves to hike. She began the activity as a way to improve her physical and mental health, and it has turned into so much more. On April 26, Marie, alongside family and friends, hiked for a different reason: to fight bone cancer.
Runner's World article features UNC research on benefits of exercise for breast cancer survivors
An article on the benefits of exercise for breast cancer survivors recently published on the Runner's World website is based off of research published by UNC Lineberger member and Associate Professor of Exercise and Sport Science, Claudio Battaglini, PhD.
UNC Lineberger to offer sequencing expertise to NCI clinical trials networks
Personalized medicine holds great promise for delivering targeted treatments to patients based on their unique genetic characteristics. Through a $3.5 million, five-year grant from the National Cancer Institute (NCI), UNC Lineberger Comprehensive Cancer Center will provide high-throughput RNA and DNA sequencing and regulatory assistance to partner institutions in the NCI's new National Clinical Trials Network (NCTN).
UNC Lineberger teams help make Pancreatic Cancer Purple Stride 5K a success
The 2014 Pancreatic Cancer Purple Stride 5K was a huge success with over $200,000 raised to support pancreatic cancer awareness and research. The event, held Saturday, May 17 on NC State's Centennial Campus, was organized by the Pancreatic Cancer Action Network. UNC Lineberger's very own - TEAM UNC and the Der Lab Team - were the top two Purple Stride fundraising teams.
UNC Lineberger announces recipient of the 2014 Marci Kramish Campbell Dissertation Award
Leanne Kaye, MPH, of the UNC Department of Nutrition has been named the 2014 recipient of the Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences.
Join the UNC/Rex team for 2014 Susan G. Komen Triangle Race for the Cure!
The 2014 Susan G. Komen Triangle Race for the Cure is scheduled for Saturday, June 14th on the campus of Meredith College in Raleigh, NC.
Dusetzina receives American Cancer Society Research Scholar Grant
The American Cancer Society (ACS) has awarded a $480,000, two-year Research Scholar Grant to Stacie B. Dusetzina, PhD, assistant professor at the UNC School of Medicine and Gillings School of Global Public Health and member of the UNC Lineberger Comprehensive Cancer Center, to support research on the impact of parity legislation on the use and costs of oral cancer medications.
UNC Lineberger announces winning posters from 9th Annual Scientific Retreat
UNC Lineberger members gathered for the 9th annual UNC Lineberger Scientific Retreat on May 14 at the Carolina Club. The retreat featured lectures from Edison Liu, president and CEO of The Jackson Laboratory, a State of the LCCC address from UNC Lineberger Director Norman Sharpless and lectures from eight UNC Lineberger members.
Deborah Mayer to be UNC Lineberger Director of Cancer Survivorship
Professor Deborah K. Mayer has been named the UNC Lineberger Director of Cancer Survivorship. In her new position, Deborah Mayer, PhD, RN, AOCN, FAAN, will lead the effort to enhance clinical and research initiatives for cancer survivors for the UNC Lineberger Comprehensive Cancer Center.
Susan G. Komen for the Cure North Carolina Triangle to the Coast Affiliate awards $50,000 grant to UNC Lineberger Comprehensive Cancer Support Program
The Susan G. Komen North Carolina Triangle to the Coast (NCTC) has awarded a $50,000 grant to UNC Lineberger Comprehensive Cancer Support Program to fund a project aimed at improving access to comprehensive lymphedema care for breast cancer patients in central North Carolina.
Board of Visitors member, Francine Netter Roberson, publishes book
UNC Lineberger Board of Visitors member, Francine Netter Roberson, has written the first major biography of her father, the legendary medical illustrator, Frank Netter, MD. Medicine's Michelangelo, The Life & Art of Frank Netter, MD (October, 2013, Quinnipiac University Press) is based on Frank Netter's private papers and published works along with the remembrances of his family, friends and colleagues.
Jackson Laboratory CEO headlines 9th Annual UNC Lineberger Scientific Retreat
The UNC Lineberger Comprehensive Cancer Center will hold its 9th Annual Scientific Retreat on May 14 at the Carolina Club. The retreat will feature lectures from Edison Liu, president and CEO of The Jackson Laboratory, a State of the LCCC address from UNC Lineberger Director Norman Sharpless and lectures from eight UNC Lineberger members.
Commemorative tile honors Clara Alston, RN
Clara Alston had a 37 year career as a newborn critical care nurse at N.C. Children's Hospital. When Clara began working at UNC in 1975, newborn critical care units were just starting to pop up in hospitals. By the time she retired from her position as assistant nurse manager in the Newborn Critical Care Center (NCCC) in 2012, Clara was an expert in the field of newborn critical care. She often shared stories about the early days and the evolution of newborn critical care nursing.
Betty Ray McCain honored with UNC Lineberger's Outstanding Service Award
Betty Ray McCain has given much of herself to UNC Lineberger. She has been a member of the UNC Lineberger Board of Visitors since 2005. Most recently, she served as chair of the Membership and Nominating Committee. Prior to that, she ably served as vice chair from 2007-2009 and chaired the board from 2009-2012.
Stepping up to raise funds, awareness for bladder cancer
Team UNC Lineberger participated in Saturday's Bladder Cancer Advocacy Network's (BCAN) Annual Walks for Bladder Cancer.
UNC Lineberger teams to participate in Pancreatic Cancer Purple Stride 5K
UNC Lineberger will be well represented at the 2014 Pancreatic Cancer Purple Stride 5K. The event, organized by the Pancreatic Cancer Action Network, helps raise awareness and research funds for pancreatic cancer.
Major named American Cancer Society Research Scholar
The American Cancer Society (ACS) has named Ben Major, PhD, assistant professor with the University of North Carolina School of Medicine and UNC Lineberger Comprehensive Cancer Center member, as a 2014 Research Scholar.
New leadership for UNC Lineberger Board of Visitors
The UNC Lineberger Board of Visitors elected new leaders at its spring meeting in April. Richard Stevens of Cary, NC was elected to serve as chair, and Jean Kitchin of Scotland Neck, NC will serve as vice chair. Their terms will begin on July 1, 2014.
UNC Lineberger teams with Duke, WUSTL to speed drug development
A partnership formed by UNC Lineberger Comprehensive Cancer Center, the Duke Cancer Institute and the Siteman Cancer Center at Washington University in St. Louis will become part of a national network working to accelerate the pace of cancer drug development.
Two UNC Lineberger members named Kimmel Scholars
The Sidney Kimmel Foundation for Cancer Research has named Greg Wang, PhD, and Qing Zhang, PhD, as 2014 Sidney Kimmel Scholars.
UNC researchers discover "master regulator" role for little-known protein in cancer cells
Previously thought to only play a role in male fertility, the protein DAZAP1 has now been shown to be a major player in how genes are expressed; in cell culture experiments it stifled the progression of several types of cancer cells.
News and Observer article on e-cigarette regulation features UNC Centers for Tobacco Regulatory Science
A News and Observer article on the role of Triangle organizations in guiding the efforts of federal regulators crafting regulations for e-cigarettes features the work of work of UNC Lineberger members Kurt Ribisl, PhD, and Adam Goldstein, MD, MPH.
Sharpless and Kim inducted at American Association of Physicians and American Society for Clinical Investigation meeting, Rathmell elected ASCI Treasurer
Norman Sharpless, MD, Director of the UNC Lineberger Comprehensive Cancer Center has been inducted as a member of the American Association of Physicians (AAP). His induction was announced at the joint American Society for Clinical Investigation (ASCI)/American Association of Physicians meeting in Chicago.
UNC Lineberger honored to be a part of 2014 Tar Heel 10 Miler
On April 26, more than 6,000 people participated in the 7th Annual Tar Heel 10 Miler
UNC Lineberger selected to join A Survivor Action Partnership to improve the lives of prostate cancer survivors
UNC Lineberger has been selected to participate in A Survivor Action Partnership – United States of America (ASAP USA), a consortium of institutions that will collaborate to develop and study interventions to improve the lives of prostate cancer survivors in the United States. Sixteen institutions were selected following a peer reviewed application process. Ronald Chen, MD, MPH, assistant professor of radiation oncology is leading the UNC Lineberger ASAP USA team.
UNC Lineberger's Matt Foster, MD, vies for the Leukemia & Lymphoma Society's Man of the Year title
The Leukemia & Lymphoma Society's Man & Woman of the Year (MWOY) campaign is a national fundraising competition in which participants vie for the title of Man or Woman of the Year. They raise funds for blood cancer research in honor of local children who are blood cancer survivors. The titles are awarded to the men and women who raise the most funds during the campaign in their communities. The top local fundraisers in the country also win the national titles.
Solving Cancer's Secrets: 5 Questions with Dr. Chuck Perou
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
UNC researchers develop insights into protein linked to cell movement
Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of origin and migrate throughout the body.
Mayer Receives Funds to Implement Survivorship Care Plans
UNC Lineberger member Deborah K. Mayer, PhD, RN, AOCN, FAAN, was awarded $50,000 in funding through the UNC School of Medicine's Institute for Healthcare Quality Improvement seed grant program for her proposal "Implementing Survivorship Care Plans."
Andrew Tucker: Building a Better Image
Andrew Tucker, PhD, used his graduate experience at UNC to help build a new kind of mammographic imaging machine now in use in a clinical trial at the North Carolina Cancer Hospital.
Pope Foundation gives $1.3 million to UNC Lineberger to fight cancer
The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.
Johnson joins 'Dream Team' of scientists collaborating on rare pediatric cancer
UNC Lineberger member Gary Johnson, PhD, professor and chair of the UNC Department of Pharmacology, has been tapped to join Synodos, a team of scientists working together to defeat the rare genetic disorder neurofibromatosis type 2 (NF2). A first-of-its-kind NF research collaboration, Synodos has brought together centers of excellence from institutions across the country. Johnson will be just one of 12 academic researchers in the collaboration.
Join the Walk for Bladder Cancer on May 3, 2014 in Hillsborough
Please join Team Lineberger for the Bladder Cancer Advocacy Network (BCAN) annual walk to raise awareness about bladder cancer on May 3, 2014 in Hillsborough, NC.
Studies examine the role of physical force on cells
The push and pull of physical force can cause profound changes in the behavior of a cell. Two studies from researchers working at the UNC Lineberger Comprehensive Cancer Center reveal how cells respond to mechanical manipulation.
UNC Lineberger to be involved in first research challenge using Project Data Sphere Initiative, a new data sharing platform launched by CEO Roundtable on Cancer
UNC Lineberger Comprehensive Cancer Center has contributed to the development of the first national "research challenge" involving the newly launched Project Data Sphere, LLC (PDS), an independent not-for-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium (LSC).
Opening of Marsico Hall marks major step for cancer research at UNC
UNC Lineberger helped celebrate the opening of Marsico Hall today, the newest research building to house an impressive array of programs, including several affiliated with the cancer center.
Evans and Perou featured in Science Magazine article on breast cancer genes
Science Magazine interviewed UNC Lineberger members Charles Perou, PhD, and James Evans, MD, PhD, for a special feature on "The 'Other' Breast Cancer Genes."
Grant will fund research into role of cancer-related genes
Researchers at the UNC Lineberger Comprehensive Cancer Center and the University of Texas Southwestern Medical Center will investigate the role of proteins linked both to human sexual reproduction and cancer tumor formation thanks to a grant from the U.S. Department of Defense (DoD).
UNC Lineberger members to share expertise at 2014 AACR Annual Meeting
Members of the UNC Lineberger Comprehensive Cancer Center will share their research and expertise at the 105th Annual Meeting of the American Association for Cancer Research (AACR) on April 5 to 9 in San Diego, Calif. The event will host more than 18,000 researchers, patient advocates and other professionals in the cancer field to share the year's foremost basic science, translational and clinical advances.
UNC researchers show cancer chemotherapy accelerates 'molecular aging'
Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.
UNC to celebrate dedication of Marsico Hall March 27
The University of North Carolina at Chapel Hill will dedicate Marsico Hall (formerly called the IRB building or the BRIC building) at 3:30 p.m. Thursday, March 27.
UNC to celebrate dedication of Marsico Hall March 27
The University of North Carolina at Chapel Hill will dedicate Marsico Hall (formerly called the IRB building or the BRIC building) at 3:30 p.m. Thursday, March 27. The event will also begin streaming live online once the ceremony has begun.
UNC scientists reveal how cells destroy RNA, a key piece in understanding disease
RNA encodes the proteins that play a key role in cellular reproduction, but the manner in which cells regulate its removal once these proteins are synthesized remains a mystery. One piece of this mystery has been solved as researchers at the University of North Carolina at Chapel Hill who have identified the steps by which a cell removes RNA from the cytoplasm.
MBCN to hold annual Metastatic Breast Cancer Conference with UNC Lineberger in September
The Metastatic Breast Cancer Network (MBCN) is pleased to announce it will hold its 8th Annual National Conference September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina
Olshan named Hulka Distinguished Professor
Andrew Olshan, PhD, professor and chair of the UNC Gillings School of Global Public Health's Department of Epidemiology and UNC Lineberger associate director for population sciences, has been named the Barbara Sorenson Hulka Distinguished Professor of Cancer Epidemiology, effective March 1.
Genetic, non-invasive test could improve colon cancer screening
A non-invasive test that includes detection of the genetic abnormalities related to cancer could significantly improve the effectiveness of colon cancer screening, according to research published by a team of scientists including David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member.
Shelia Santacroce receives grant from Northwestern Mutual and the Alex's Lemonade Stand Foundation
On March 5, Shelia Santacroce, PhD, UNC Lineberger Comprehensive Cancer Center Member and Beerstecher-Blackwell Distinguished Scholar, received a $50,000 research grant from Northwestern Mutual and the Alex's Lemonade Stand Foundation (ALSF) to fund children's cancer research.
Dr. Chad Ellis named UNC Lineberger associate director
Chad Ellis, PhD, has been appointed as associate director of UNC Lineberger Comprehensive Cancer Center, effective April 1, 2014.
Community physician and researcher partnerships deliver latest care to breast cancer patients
Cancer patients who receive care from local physicians partnering with the medical research community are as likely to receive innovative treatments compared to patients treated at medical school affiliated hospitals, according to research from the University of North Carolina at Chapel Hill.
Local 5K kicks off Colorectal Cancer Awareness month, raises funds for screening programs
Across the country, thousands have taken part in the Colon Cancer Coalition's initiative called "Get Your Rear In Gear," a series of 5K races aimed at fighting colon cancer by raising funding to support education, prevention and screening programs. On March 1, supporters gathered in Raleigh, N.C. to kick off Colorectal Cancer Awareness month with their local Get Your Rear in Gear event.
UNC researchers create new tool to unravel mysteries of metastasis
The lab of Klaus Hahn, PhD, developed a new technique to help scientists map the interactions between the proteins at the heart of many diseases.
Groesbeck Parham receives humanitarianism and volunteerism award
Parham is being recognized by the Society for Gynecologic Oncology for his work on cervical cancer and selfless dedication to improving the lives of women in Zambia.
Beth Knight: Inside Our Cellular Invaders
Beth Knight found out what transpires inside cells involved in medulloblastoma - a type of brain cancer - and what role a particular protein plays in tumor development.
Heels of Hope program trains lay navigators to support patients at N.C. Cancer Hospital
The program prepares volunteers to provide patients and their families with practical and emotional guidance as they receive treatment.
Endeavors - Chasing Pac-Man
Two UNC researchers design a biological test to individualize chemotherapy.
Weiss teams up with GRACE to offer free webinar for late stage oropharynx cancer patients
UNC Lineberger Comprehensive Cancer Center member Jared Weiss, MD is teaming up with the cancer advocacy organization Global Resource for Advancing Cancer Education (GRACE) to offer a free webinar
UNC Lineberger members make major contribution to President's Cancer Panel report on HPV vaccination
Members of the University of North Carolina Lineberger Comprehensive Cancer Center played a major role in developing the recommendations in a President's Cancer Panel (PCP) report urging a widespread public campaign to increase the rate of human papillomavirus (HPV) vaccination.
Baron aspirin research profiled in the Boston Globe
The work of UNC School of Medicine Professor and Lineberger member John Baron, MD, is featured in an article titled "Can aspiring fight cancer?" The article provides an overview of recent studies that suggest regular doses of aspirin can help prevent some types of cancer.
UNC Lineberger faculty headline AACR RAS conference
The oncogene RAS is linked to 30 percent of human cancers, but the search for a targeted therapy for RAS has remained elusive. Three leading RAS researchers from the University of North Carolina Lineberger Comprehensive Cancer Center are playing leading roles at a conference aimed at discussing recent advances that may lead to new advances in targeting the oncogene.
Clinical advances should not yet discourage the use of local therapies
Clinical trials that show positive patient response to systemic therapies for cancer should not necessarily lead to reduction in the use of local therapies such as radiation and surgery.
UNC's Dr. Jared Weiss joins Lung Cancer Initiative of North Carolina's Board
The Lung Cancer Initiative of North Carolina (LCINC), the state's leading non-profit organization supporting lung cancer research and education, is proud to welcome Dr. Jared Weiss, medical oncologist with UNC Lineberger Comprehensive Cancer Center's Thoracic Oncology Program, to serve on the board of directors.
Harris comments on major mammography study in The New York Times
UNC Lineberger member Russell Harris, MD, MPH, Professor of Medicine in the UNC School of Medicine and Adjunct Professor of Epidemiology in the UNC Gillings Global School of Public Health, was quoted in two articles in the New York Times about a major study of the efficacy of breast cancer screening published by BMJ (formerly British Medical Journal).
Genetic subtypes of bladder cancer reflect breast cancer biology
A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.
Makowski study explores impact of glucose uptake on inflammatory processes
"This is an important finding because of the field's increased interest in 'metabolic reprogramming' of immune cells. Understanding how macrophage substrate metabolism impacts inflammation is crucial to our being able to develop novel therapies for obesity and diabetes, and even cancer," said study author Liza Makowski, PhD, assistant professor of nutrition at the Gillings School and member of the UNC Lineberger Comprehensive Cancer Center.
UNC Lineberger receives jointly awarded $1 million research grant to investigate novel target in melanoma
The $1 million award from the Melanoma Research Alliance and the Saban Family Foundation will support research to improve the treatment of melanoma, the most aggressive type of skin cancer.
NIH grant to improve efficiency of chemotherapy drugs
A team led by Cyrus Vaziri, PhD, and William Janzen at the University of North Carolina at Chapel Hill has received a grant from the National Institutes of Health for research that could help make chemotherapy drugs more effective.
Early tumor response from stereotactic radiosurgery predicts outcome
The response of a patient with metastatic brain tumors to treatment with stereotactic radiosurgery in the first six-to-twelve weeks can indicate whether follow-up treatments and monitoring are necessary, according to research conducted at the University of North Carolina.
Application sought for 2014 Marci K. Campbell Dissertation Award
The UNC Lineberger Comprehensive Cancer Center announces The Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences. This cash award goes directly to the recipient and can be used for any purpose.
Nature Reviews features Smith bladder cancer research
The journal highlights research performed by UNC Lineberger member Angela Smith, MD, that links a loss of muscle mass, known as sarcopenia, in women to complications from a cystectomy. Women who experienced sarcopenia were found to have a 43 percent chance of major complications compared to 10 percent for women who did not experience muscle loss.
Improved ultrasound imaging provides an alternative way of visualizing tumors
While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans and MRIs, the lower clarity and resolution of ultrasound has limited its use in cancer treatment. Researchers at the University of North Carolina at Chapel Hill have overcome this limitation by combining ultrasound with a contrast agent comprised of micro-sized bubbles that pair with an antibody produced at elevated levels by many cancers.
A powerful technique to further understanding of RNA
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.
MSN Student Sean Gallagher Receives ONS Fellowship
The Oncology Nursing Society Foundation selected MSN student Sean Gallagher, RN, for a 2013 APN/DNP Student Fellowship. Mr. Gallagher's fellowship will cover the costs of his research project "Survivors of HPV-Related Oropharyngeal Cancer--Knowledge of Human Papillomavirus (HPV) and Impact of HPV on Sexual Intimacy."
Best Doctors in America® 2014 list includes 53 UNC Lineberger physicians
The annual compilation of The Best Doctors in America® includes 53 physicians affiliated with the University of North Carolina's Lineberger Comprehensive Cancer Center.
Endeavors - Radiation Revolution
Sha Chang, Otto Zhou, and collaborators have built the first small device that can produce these kind of microbeams, opening up a new area of research for cancer scientists.
Carey on breast cancer at MedPage Today
Dr. Lisa Carey, MD, medical director of the UNC Breast Center and associate director for clinical science at UNC Lineberger Comprehensive Cancer Center, is one of the experts interviewed by MedPage Today on recent advances in cancer research.
Top of the Line - Five questions with Dr. Sharpless
The next chapter in the story of UNC Lineberger Comprehensive Cancer Center begins with a new director, Ned Sharpless, an oncologist with a story to tell.
Cancer patient out-of-pocket costs play major role in treatment adherence
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient's share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.
The Charlotte Observer - Mersereau comments on fertility preservation for young adults battling cancer
Dr. Jennifer Mersereau, a fertility preservation specialist at UNC Cancer Care, comments on the promise and challenge of fertility preservation for individuals battling cancer.
UNC Lineberger announces 2013 Excellence Awards
UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care honored four employees with 2013 Excellence Awards.
Associated Press - Coach Hatchell vows to coach again
UNC Women's Basketball Coach Sylvia Hatchell talked to the Associated Press about her fight to get back to her basketball program as quickly as possible.
UNC Department of Urology participates in Movember Campaign
Movember is a national campaign where teams are inspired to raise money, and grow mustaches, to support men's health.
John Isner hosts 4th Annual Ebix Charity Challenge
On December 7, 2013, America's No. 1 tennis player, John Isner, held his annual charity event, the Ebix Charity Challenge, contributing $75,000 to UNC Lineberger
Screening decisions must balance potential benefits with potential patient harms
Screening to detect medical conditions has become standard practice for many diseases, but insufficient attention has been paid to the potential for harm, according to research by a team led by Russell Harris, MD, MPH, of the UNC School of Medicine, UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center member.
End-of-year deadlines for gifts to receive tax benefits for 2014
We are deeply grateful to the thousands of donors who help make UNC Lineberger's cancer fight possible by supporting innovative and lifesaving cancer research and care. Here are important year-end gift deadlines and reminders to receive tax benefits for calendar 2014.
Evans on 23andMe genetic testing controversy in The Cancer Letter
James Evans, MD, PhD, published his thoughts on the 23andMe genetic testing controversy in the Dec. 13 issue of The Cancer Letter.
Muss honored with ACTO Richard L. Schilsky Award
The award recognizes Hyman B. Muss, MD, for his years of service to the Richard L. Schilsky Cancer and Leukemia Group B cooperative group.
Combined therapy reduces recurrence in women with small, HER2+ breast cancers
A new study shows combined therapy is linked to a lower chance of recurrence in women with small, HER2+ breast cancers.
Chapel Hill News - UNC starts support group for fathers widowed by cancer
UNC Lineberger's Single Fathers Due to Cancer program featured in the Chapel Hill News.
DeSimone named to National Academy of Inventors
The National Academy of Inventors Fellows were nominated by their peers for outstanding contributions to innovation.
UNC Lineberger leadership offers insight at 2013 San Antonio Breast Cancer Symposium
UNC Lineberger members Charles Perou, PhD, Lisa Carey, MD, Carey Anders, MD, and Hyman B. Muss, MD will present at symposium.
Songwriters connect over cancer treatment and recovery
N.C. Cancer Hospital patient, Jim MacDonald, worked with songwriter, Emily Lynch, to write a song about his cancer experience, "Every Day is Christmas."
Five Questions for Yisong Wan: Understanding our immunity
Five questions for Yisong Wan, PhD, a new Jefferson-Pilot fellow who is uncovering the roles of T cells in disease cures and causes.
Approaches to pain assessment in cancer clinical trials
Director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center and colleagues at the FDA guide drug developers on how to include meaningful pain endpoints when designing cancer trials.
Daily Tar Heel - Program provides cancer patients student support
The Carolina Pediatric Attention, Love, and Support program pairs UNC students with young people undergoing treatment for cancer and blood disorders, Josephine Yurcaba of the Daily Tar Heel reports.
News & Observer - UNC Lineberger support group member featured in book review
Bruce Ham, one of the original members of the Single Fathers Due to Cancer support group, has written a memoir, "Laughter, Tears and Braids," about his journey raising three daughters after the death of his wife from cancer.
Carolina Breast Cancer Study enrolls record 3,000 participants
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
UNC Lineberger part of national #GivingTuesday movement
The Tuesday after Thanksgiving is intended to create a national movement around the holidays dedicated to giving.
Supporting others brings healing to cancer survivors
A new study led by Christine Rini, PhD, finds that survivors of hematopoietic stem cell transplant, an aggressive treatment for blood cancers, benefited from a two-part peer support process the authors call expressive helping.
NPR - FDA tells Google-backed 23andMe to stop selling DNA test
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, was quoted on National Public Radio's All Things Considered regarding the Food and Drug Administration's warning letter sent to the company 23andMe demanding that its saliva test be taken off the market.
Be The Match bone marrow registry event Dec 2 and 3 on UNC campus
Give back this holiday season by registering with Be The Match on UNC's campus on December 2 and 3, 2013.
Herald-Sun - Grateful for each day
Stella Waugh, a cancer survivor, is thankful to have family together for Thanksgiving, April Dudash of the Durham Herald-Sun reports.
University Gazette - Humphries helps countless children escape through books
For the fifth straight year, UNC Libraries and campus collect books for the Pediatric Hematology-Oncology clinic.
HPV associated with increased risk of HIV infection in men
A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.
Family House Diaries: Salie Babilonia - How "The Look" Speaks Volumes
A Dare County, N.C., wife and mother of three keeps her spunky, positive spirit intact during treatment for thyroid cancer, buoying herself, her family and her medical team on the journey.
Probe measuring immune function can be used to determine nanoparticle dosage for patients
William Zamboni, PharmD, PhD, has developed a probe to measure the body's immune function to help physicians deliver accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs
UNC Lineberger holds first community-oriented geriatric oncology symposium
The inaugural geriatric oncology symposium, geared toward a lay audience, provided a lively afternoon of presentations, questions and answers, and concluded with a reception on Friday, November 15, 2013.
Huang receives prestigious Distinguished Pharmaceutical Scientist Award
The award is the highest distinction awarded by the American Association of Pharmaceutical Scientists.
Channing Der presents lecture at Pancreatic Cancer Action Network
Der highlighted recent research findings that have stimulated new experimental directions for improve therapies for pancreatic cancer.
Obesity found to be major risk factor in developing basal-like breast cancer
Women who are obese face an increased risk of developing an aggressive sub-type of breast cancer known as 'basal-like', according to research conducted at the University of North Carolina at Chapel Hill.
Media coverage of celebrity cancer cases impacts public awareness and cancer screening
When celebrities battle cancer, their stories make headlines around the world. Whether announcing their prognosis, seeking treatment or losing their battle, celebrities faced with cancer have a profound impact on the public – one that leads to increased interest in cancer information and screening, according to research by the University of North Carolina.
Conquering Chromatin
Five questions for Greg Wang, a new Jefferson-Pilot fellow searching for better ways to shut down cancer cells.
real doctors, real people - Adam Goldstein
In October 2013, Adam Goldstein, MD, MPH, embarked on an incredible journey taking him to the heartland of civilization's beginning.
Nielsen presents at Best Doctors' Global Grand Rounds
Matthew Nielsen, MD, MS, FACS, presents on "Active Surveillance for Prostate Cancer" for the Global Grand Rounds hosted by Best Doctors.
Cyberknife treatment provides a promising option for patients with early prostate cancer
Stereotactic body radiation therapy is an effective treatment option that is cost-effective and convenient for patients.
UNC Libraries organizes book drive for pediatric cancer patients at UNC
Book drive seeks 10,000th book for the Pediatric Oncology Clinic.
Lisa Edwards named Hometown Hero from WCHL
WCHL named Lisa Edwards a Hometown Hero for November 6, 2013. Each weekday the station selects a Hometown Hero who goes "over and above the call of duty," exemplifying excellent service and dedication to others in the community.
Emanuele receives V Scholar Award from the V Foundation
The grant will be used to further research to globally understand regulated protein degradation and how this contributes to normal cellular functions that are dysfunctional in cancer.
UNC Lineberger researchers win drug-discovery awards from pharmaceutical giant GSK
GlaxoSmithKline drug-discovery competition winners aim to find a new cancer therapy and a novel way to regulate male fertility, projects spearheaded by scientists at the UNC School of Medicine.